Nordenström et al. in a study in 2019 investigated the mortality rate and cause of death between CYP21A2 mutation carriers and population controls and suggested that carriers might experience lower mortality while facing severe infections, with a possible emphasis on pneumonia. This evidence concerns the gene CYP21A2 and susceptibility to pneumonia measurement.